113 related articles for article (PubMed ID: 1638678)
1. Detection and characterization by 32P-postlabelling of DNA adducts induced by a Fenton-type oxygen radical-generating system.
Carmichael PL; Shé MN; Phillips DH
Carcinogenesis; 1992 Jul; 13(7):1127-35. PubMed ID: 1638678
[TBL] [Abstract][Full Text] [Related]
2. Generation of putative intrastrand cross-links and strand breaks in DNA by transition metal ion-mediated oxygen radical attack.
Lloyd DR; Phillips DH; Carmichael PL
Chem Res Toxicol; 1997 Apr; 10(4):393-400. PubMed ID: 9114975
[TBL] [Abstract][Full Text] [Related]
3. 32P-postlabelling analysis of small aromatic and of bulky non-aromatic DNA adducts.
Reddy MV
IARC Sci Publ; 1993; (124):25-34. PubMed ID: 8225492
[TBL] [Abstract][Full Text] [Related]
4. 32P-postlabelling method for the detection of 7-alkylguanine adducts formed by the reaction of different 1,2-alkyl epoxides with DNA.
Kumar R; Staffas J; Försti A; Hemminki K
Carcinogenesis; 1995 Mar; 16(3):483-9. PubMed ID: 7697802
[TBL] [Abstract][Full Text] [Related]
5. 32P-postlabeling analysis of DNA adducts formed by leukotriene A4 (LTA4).
Funk D; Sorg BL; Lindner SC; Schmeiser HH
Environ Mol Mutagen; 2010 May; 51(4):338-43. PubMed ID: 20120015
[TBL] [Abstract][Full Text] [Related]
6. 32P-postlabeling of acrolein-deoxyguanosine adducts in DNA after nuclease P1 digestion.
Maccubbin AE; Lee L; Struck RF; Gurtoo HL
Chem Biol Interact; 1992 Sep; 84(1):21-35. PubMed ID: 1394614
[TBL] [Abstract][Full Text] [Related]
7. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method.
Gorelick NJ; Wogan GN
Carcinogenesis; 1989 Sep; 10(9):1567-77. PubMed ID: 2670301
[TBL] [Abstract][Full Text] [Related]
8. 32P-postlabeling analysis of adducts formed from 1-phenylazo-2-hydroxynaphthalene (Sudan I, Solvent Yellow 14) with DNA and homopolydeoxyribonucleotides.
Stiborová M; Frei E; Schmeiser HH; Wiessler M
Carcinogenesis; 1992 Jul; 13(7):1221-5. PubMed ID: 1638690
[TBL] [Abstract][Full Text] [Related]
9. Detection of bulky DNA lesions in the liver of patients with Wilson's disease and primary haemochromatosis.
Carmichael PL; Hewer A; Osborne MR; Strain AJ; Phillips DH
Mutat Res; 1995 Feb; 326(2):235-43. PubMed ID: 7529889
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibition by N-acetylcysteine of oxidative DNA modifications detected by 32P postlabeling.
Izzotti A; Orlando M; Gasparini L; Scatolini L; Cartiglia C; Tulimiero L; De Flora S
Free Radic Res; 1998 Feb; 28(2):165-78. PubMed ID: 9645393
[TBL] [Abstract][Full Text] [Related]
11. The use of 32P-postlabelling in studies of the nature and origin of DNA adducts formed by bile from patients with familial adenomatous polyposis and from normal patients.
Scates DK; Spigelman AD; Phillips RK; Venitt S
Mutat Res; 1997 Aug; 378(1-2):113-25. PubMed ID: 9288890
[TBL] [Abstract][Full Text] [Related]
12. Separation of 32P-labelled nucleoside 3',5'-bisphosphate adducts by HPLC.
Pfau W; Lecoq S; Hughes NC; Seidel A; Platt KL; Grover PL; Phillips DH
IARC Sci Publ; 1993; (124):233-42. PubMed ID: 8225490
[TBL] [Abstract][Full Text] [Related]
13. Analysis of tamoxifen-induced DNA adducts by 32P-postlabelling assay using different chromatographic techniques.
Koskinen M; Rajaniemi H; Hemminki K
J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):155-60. PubMed ID: 9140769
[TBL] [Abstract][Full Text] [Related]
14. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
Randerath K; Liehr JG; Gladek A; Randerath E
IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
[TBL] [Abstract][Full Text] [Related]
15. Detection by 32P-postlabelling of DNA adducts induced by free radicals and unsaturated aldehydes formed during the aerobic decomposition of fecapentaene-12.
Povey AC; Wilson VL; Zweier JL; Kuppusamy P; O'Neill IK; Harris CC
Carcinogenesis; 1992 Mar; 13(3):395-401. PubMed ID: 1547529
[TBL] [Abstract][Full Text] [Related]
16. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
Randerath K; Randerath E; Danna TF; van Golen L; Putman KL
Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
[TBL] [Abstract][Full Text] [Related]
17. HPLC enrichment of hydrophobic DNA--carcinogen adducts for enhanced sensitivity of 32P-postlabeling analysis.
Dunn BP; San RH
Carcinogenesis; 1988 Jun; 9(6):1055-60. PubMed ID: 3286027
[TBL] [Abstract][Full Text] [Related]
18. Differences in detection of DNA adducts in the 32P-postlabelling assay after either 1-butanol extraction or nuclease P1 treatment.
Gallagher JE; Jackson MA; George MH; Lewtas J; Robertson IG
Cancer Lett; 1989 Apr; 45(1):7-12. PubMed ID: 2540901
[TBL] [Abstract][Full Text] [Related]
19. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
Wohlin P; Zeisig M; Gustafsson JA; Möller L
Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
[TBL] [Abstract][Full Text] [Related]
20. 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II.
Pfau W; Schmeiser HH; Wiessler M
Carcinogenesis; 1990 Sep; 11(9):1627-33. PubMed ID: 2401053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
